company background image
IGPH logo

IGEA Pharma SWX:IGPH Stock Report

Last Price

CHF0.0015

Market Cap

CHF505.5k

7D

200.0%

1Y

-96.9%

Updated

20 Dec, 2023

Data

Company Financials

IGPH Stock Overview

IGEA Pharma N.V. commercializes health-tech and med-tech products and devices in the Netherlands and rest of Europe.

IGPH fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

IGEA Pharma N.V. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IGEA Pharma
Historical stock prices
Current Share PriceCHF0.0015
52 Week HighCHF0.05
52 Week LowCHF0.001
Beta-1.31
1 Month Change200.00%
3 Month Change-25.00%
1 Year Change-96.88%
3 Year Change-99.72%
5 Year Change-99.94%
Change since IPO-99.94%

Recent News & Updates

Recent updates

Shareholder Returns

IGPHCH Medical EquipmentCH Market
7D200.0%0.5%0.8%
1Y-96.9%15.8%3.3%

Return vs Industry: IGPH underperformed the Swiss Medical Equipment industry which returned 19.8% over the past year.

Return vs Market: IGPH underperformed the Swiss Market which returned 3.3% over the past year.

Price Volatility

Is IGPH's price volatile compared to industry and market?
IGPH volatility
IGPH Average Weekly Movement123.2%
Medical Equipment Industry Average Movement3.7%
Market Average Movement3.4%
10% most volatile stocks in CH Market7.7%
10% least volatile stocks in CH Market1.8%

Stable Share Price: IGPH's share price has been volatile over the past 3 months.

Volatility Over Time: IGPH's weekly volatility has increased from 75% to 123% over the past year.

About the Company

FoundedEmployeesCEOWebsite
20151Pierpaolo Ceranihttps://www.igeapharma.nl

IGEA Pharma N.V. commercializes health-tech and med-tech products and devices in the Netherlands and rest of Europe. It offers Alz1, an at-home lab test kit to measure non-bound copper in the blood; functional foods; and dietary supplement products to reduce blood heavy metals content under the Alz1 Tab brand. The company also provides dry aerosol generators for air and inanimate environmental surfaces sanitization, as well as air sterilization and purification devices.

IGEA Pharma N.V. Fundamentals Summary

How do IGEA Pharma's earnings and revenue compare to its market cap?
IGPH fundamental statistics
Market capCHF505.55k
Earnings (TTM)-CHF10.92m
Revenue (TTM)n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IGPH income statement (TTM)
Revenue€0
Cost of Revenue€0
Gross Profit€0
Other Expenses€11.56m
Earnings-€11.56m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.034
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio-47.1%

How did IGPH perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.